Welcome to our dedicated page for Terrascent SEC filings (Ticker: TSNDF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
TerrAscend Corp. (TSNDF) files reports and disclosures with the U.S. Securities and Exchange Commission that provide additional detail on its North American cannabis operations, financing activities and material events. As a Canadian issuer whose common shares trade on the OTCQX Best Market, TerrAscend uses SEC filings such as Form 8-K to furnish press releases and describe significant transactions.
On this page, you can review TerrAscend’s Form 8-K filings that report material developments. For example, the company has filed an 8-K describing its quarterly financial results and business highlights for a specific period, incorporating a related press release by reference. Another 8-K details the Union Chill transaction, in which TerrAscend and certain consolidated entities entered into an option agreement with Union Chill Cannabis Company LLC, a dispensary operator in Hunterdon County, New Jersey. That filing explains the structure of the option to acquire a 35% equity interest, the issuance of convertible promissory notes, the total consideration and the conversion terms for the notes.
These filings also clarify that TerrAscend’s common shares trade on the OTCQX Best Market under the symbol TSNDF and identify the company as a Canadian issuer with a specific Commission File Number. The Union Chill 8-K further notes that the convertible notes and any common shares issuable upon conversion were offered and sold in reliance on an exemption from registration under Section 4(a)(2) of the U.S. Securities Act of 1933.
Stock Titan’s SEC filings page presents TerrAscend’s submissions as they are made available on EDGAR and pairs them with AI-powered summaries to help explain key terms, such as the nature of an 8-K, the implications of unregistered sales of equity securities, and how options, convertible notes and other instruments may affect the company’s capital structure. Investors can use this resource to quickly understand what TerrAscend is disclosing in its U.S. regulatory documents without having to parse every technical detail themselves.
TerrAscend Corp. granted its Chief Financial Officer, Eric Matthew Jackson, stock options covering 300,000 common shares. The options have an exercise price of $0.76 per share and expire on April 27, 2036. They vest in four equal annual installments beginning on the first anniversary of the grant date, aligning compensation with longer-term company performance.
TerrAscend Corp. filed an initial insider ownership report for Eric Matthew Jackson, who serves as Chief Financial Officer. This Form 3 filing establishes his status as a reporting insider. The provided data show no reported buy, sell, or other share transactions in this filing.
TerrAscend Corp. reported preliminary, unaudited first-quarter 2026 results from continuing operations, excluding Michigan, which is treated as discontinued. The Company expects net revenue of $65.5 million, slightly above the first quarter of 2025 but modestly below the fourth quarter of 2025. Gross profit margin is anticipated at 52.8%, essentially in line with recent periods. General and administrative expenses were flat quarter-over-quarter, and TerrAscend generated positive cash flow from operations for the 15th consecutive quarter, highlighting ongoing cash generation.
Management cited year-over-year revenue growth from continuing operations and profitability metrics exceeding internal targets. TerrAscend also referenced recent U.S. federal rescheduling of certain medical cannabis to Schedule III and an upcoming hearing on broader rescheduling, noting that federal law and enforcement remain a significant risk. The Company plans to discuss detailed first-quarter 2026 results on an earnings conference call on May 7, 2026 at 8:00 a.m. Eastern Time.
TerrAscend Corp. has called a fully virtual annual meeting for June 9, 2026 at 1:00 p.m. Eastern Time to let shareholders vote on key governance and compensation matters. Holders of common shares as of April 13, 2026 can vote one share per vote.
Shareholders will elect five directors, ratify MNP LLP as auditor for 2026, and vote on renewing all unallocated awards under TerrAscend’s rolling Stock Option Plan and Share Unit Plan, which together may cover up to 15% of outstanding shares. The circular also highlights U.S. federal legal risks to its cannabis operations and outlines detailed proxy, broker, and virtual participation procedures.
TerrAscend Corp. appointed Eric Jackson as Chief Financial Officer, effective April 27, 2026. Jackson has more than two decades of finance and operational leadership experience, including senior roles at American Signature and L Brands supporting large, multi-location retail businesses.
Under his employment agreement, Jackson will receive a $450,000 annual base salary, a target annual bonus equal to 60% of salary (with the 2026 bonus guaranteed on a pro rata basis), and annual restricted stock units valued at up to 75% of salary. He will also receive options to purchase 300,000 common shares, vesting in four equal annual installments and carrying a ten-year term.
If his employment is terminated without cause or he resigns for good reason, Jackson is entitled to 12 months of salary as severance, a cash amount equal to 12 months of the company’s share of his medical coverage, specified bonus payments, and pro rata vesting of unvested options and RSUs. In a qualifying termination within 24 months after a change of control, cash severance and medical stipends increase to two times these amounts and all unvested equity vests. Post-employment, he is subject to non-solicitation and non-competition covenants for 12 months.
TerrAscend Corp. Chief People and Legal Officer Lynn K. Gefen reported routine share withholdings to cover taxes on equity compensation. On two dates, a total of 13,003 Common Shares were withheld by the company to satisfy tax obligations tied to restricted share unit settlement under its equity plan. After these tax-withholding dispositions, Gefen directly holds 1,081,715 Common Shares.
TerrAscend Corp. reported an insider transaction by President and CEO Ziad Ghanem involving share withholdings for tax purposes rather than market sales. On two dates, the company withheld common shares to cover tax obligations tied to restricted share unit settlements under its equity plan.
The issuer withheld 22,017 common shares at $0.66 per share and 9,998 common shares at $0.62 per share, totaling 32,015 shares. After these tax-withholding dispositions, Ghanem directly owned 2,864,884 common shares of TerrAscend.
TerrAscend Corp. reported that Chief People and Legal Officer Lynn K. Gefen received an award of 540,254 restricted share units (RSUs) on common shares, which will vest in equal annual installments over four years starting on April 3, 2026, subject to continued service. In a related move, 50,879 common shares were withheld by the company at $0.68 per share to cover tax obligations tied to RSU settlement. After these transactions, Gefen directly holds 1,094,718 common shares.
TerrAscend Corp. reported that President and CEO Ziad Ghanem received an award of 1,388,040 common-share RSUs, granted at $0.00 per share. These restricted share units vest in equal annual installments over four years starting on April 3, 2026, contingent on his continuous service.
In a related transaction on April 4, 105,051 common shares were withheld at $0.68 per share to cover tax obligations arising from RSU settlement under the company’s equity plan, rather than sold in the open market. After these transactions, Ghanem directly holds 2,896,899 common shares of TerrAscend.